Cost‐Effectiveness of Primary Liver Transplantation Versus Hepatoportoenterostomy in the Management of Biliary Atresia in the United States

2021 ◽  
Author(s):  
Vikram K. Raghu ◽  
James E. Squires ◽  
Douglas B. Mogul ◽  
Robert H. Squires ◽  
Patrick J. McKiernan ◽  
...  
Keyword(s):  
United States ◽  
Liver Transplantation ◽  
Cost Effectiveness ◽  
Biliary Atresia ◽  
The United States

Donors for Liver Transplantation

PEDIATRICS ◽  
1983 ◽  
Vol 71 (5) ◽  
pp. 856-857
Author(s):  
THOMAS E. STARZL ◽  
THOMAS R. HAKALA ◽  
J. THOMAS ROSENTHAL ◽  
DON DENNY
Keyword(s):  
United States ◽  
Liver Transplantation ◽  
Biliary Atresia ◽  
Inborn Errors Of Metabolism ◽  
The United States ◽  
Good Evidence ◽  
Full Potential ◽  
Inborn Errors ◽  
Infancy And Childhood ◽  
Liver Replacement

There is good evidence that the decade of the 1980s will witness an expansion of efforts to transplant extrarenal organs. This will have a profound effect in pediatrics, and particularly in the field of hepatology. The number of infants born with biliary atresia is not known with certainty, but it is likely that there are approximately 500 new cases each year in the United States. The number of lethal hepatic based inborn errors of metabolism that can be effectively treated with liver replacement has steadily grown. Other acquired hepatic disorders are not uncommon in infancy and childhood. If transplantation of the liver (or of the kidney, heart, intestine, pancreas, and possibly other organs) is to reach its full potential, pediatricians will have to be more acutely aware of the need for organs, and will need to collaborate actively in the procurement process.

Biliary Atresia and Liver Transplantation: The National Institutes of Health Point of View

PEDIATRICS ◽  
1984 ◽  
Vol 74 (1) ◽  
pp. 159-160
Author(s):  
JOHN R. LILLY
Keyword(s):  
United States ◽  
Liver Transplantation ◽  
Biliary Atresia ◽  
Private Practice ◽  
The United States ◽  
Point Of View ◽  
National Institutes Of Health ◽  
Pediatric Department ◽  
Extrahepatic Biliary Atresia ◽  
Hospital Director

In August 1983, a bulletin, Liver Transplantation,1 printed and distributed under the aegis of the National Institutes of Health (NIH), was mailed to physicians throughout the United States. The bulletin was the product of a concensus panel convened to consider offered evidence (expert presentation of the available data) about liver transplantation. The panel was composed of a singular assortment of individuals including physicians in private practice, medical and pediatric department chairmen, a dean, a hospital director, and a person with a PhD in mathematics and statistics. Whatever the validity of their transplantation conclusions, the panel's recommendations about extrahepatic biliary atresia appear arbitrary and suspect, if not downright erroneous.

Cost-Effectiveness of Inhaled Nitric Oxide in the Treatment of Neonatal Respiratory Failure in the United States

PEDIATRICS ◽  
2003 ◽  
Vol 112 (6) ◽  
pp. 1351-1360 ◽  
Author(s):  
D. C. Angus ◽  
G. Clermont ◽  
R. S. Watson ◽  
W. T. Linde-Zwirble ◽  
R. H. Clark ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
United States ◽  
Cost Effectiveness ◽  
Respiratory Failure ◽  
The United States ◽  
Inhaled Nitric Oxide

scholarly journals Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States

2021 ◽  
Vol 24 (1) ◽  
pp. 421-431
Author(s):  
Claire L. Simons ◽  
Daniel Malone ◽  
Michael Wang ◽  
Gregory A. Maglinte ◽  
Tim Inocencio ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
The United States ◽  
Adult Patients ◽  
Car T ◽  
Mantle Cell
Sign in / Sign up

Export Citation Format

Share Document